The SalutarisMD minimally invasive ophthalmic technology for the treatment of wet AMD (a leading cause of vision loss worldwide) delivers a single dose of radiation and is designed for use in an outpatient setting in 15 mn. It has the potential to provide greater efficacy, reduce/eliminate the need for expensive monthly pharmaceutical injections and result in significant cost-savings over emerging and current treatments.